The efficacy and safety of modified DEB-TACE in the treatment of unresectable large hypervascular hepatocellular carcinoma
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 11
Abstract
Objective To retrospectively analyze the clinical efficacy and safety of the modified drug-eluting beads transcatheter arterial chemoembolization (DEB-TACE) in the treatment of unresectable large hypervascular hepatocellular carcinoma. Methods A retrospective analysis was conducted on the clinical data of 169 cases of unresectable large hypervascular hepatocellular carcinoma admitted to Linyi Cancer Hospital from January 2019 to September 2022. All patients received modified DEB-TACE treatment. The tumor response of patients at 1, 3, and 6 months after intervention was analyzed using the mRECIST standard. The disease progression time and overall survival of patients were recorded. Results A total of 169 patients underwent 403 rounds of modified DEB-TACE treatment, with an average of (2.38±0.74). At 1, 3, and 6 months after the first intervention, the objective remission rate (ORR) of the patients was 100%, 85.1%, and 75.5%, and the disease control rate (DCR) was 100%, 97.5%, and 88.8%, respectively. As of September 30, 2023, with a mean follow-up of (27.46±9.22) months, the median overall time for treated patients was 25.0 months and the median time to progression was 10.0 months. Adverse reactions associated with modified DEB-TACE were mainly fever, pain, nausea and vomiting, which were mild and relieved by symptomatic treatment, and no serious complications such as ectopic embolism occurred. ALT and AST of the patients at 1 week after DEB-TACE were differently elevated compared with the preoperative period, and all of them were returned to normal within 1 month after the operation. Conclusion The application of modified DEB-TACE in the treatment of unresectable large hypervascular hepatocellular carcinoma is significantly effective and safe.
Authors and Affiliations
LIU Song, LI Long, WANG Qingdong, YU Guangji Department of Intervention, Linyi Cancer Hospital, Linyi, Shandong 276034, China
Keywords
Related Articles
- EP ID EP751749
- DOI 10.13429/j.cnki.cjcr.2024.11.020
- Views 19
- Downloads 0
Correlation between spot sign on dual-energy CT angiography and risk of hematoma enlargement in patients with hypertensive intracerebral hemorrhage
"<b>Objective</b> To investigate the correlation between spot sign (SS) on energy computed tomography angiography (CTA) and the risk of hematoma enlargement (HE) in patients with hypertensive intracerebral hemorrhage (HI...
Research progress on sepsis complicated with acute respiratory distress syndrome
Sepsis is a clinically common critical illness with high mortality rate. Acute respiratory distress syndrome (ARDS), an acute inflammatory lung injury disease, is a common complication during the development of sepsis an...
Current status and progress in research on postoperative acute kidney injury
Postoperative acute kidney injury (AKI) is one of the common complications of major surgery, associated with mortality and long-term adverse events. The Kidney Disease: Improving Global Outcomes (KDIGO) has proposed the...
Efficacy and prognosis of transurethral holmium laser en-blocresection of bladder tumor in the treatment of non-invasive bladder cancer
Objective To investigate the efficacy and prognosis of transurethral holmium laser en-bloc resection of bladder tumor (HOLRBT) and transurethral resection of bladder tumor (TURBT) in the treatment of non-invasive bladder...
Research progress of amino acid metabolism regulating PI3K/AKT/mTOR signaling pathway in gastric cancer
In the tumor microenvironment, amino acids are important nutrients constituting immune cells and tumor cells. Some proteins or key enzymes in the metabolism process are expected to become tumor diagnostic markers or ther...